ArticleOpen forum infectious diseases2021

In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2.

Kyle Laurie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.